Bank of New York Mellon
ORMP icon

Bank of New York Mellon’s Oramed Pharmaceuticals ORMP Stock Holding History

Bank of New York Mellon’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Buy
+79,255
New +$315K ﹤0.01% 3876
2022
Q2 		– Sell
-97,284
Closed -$842K – 4672
2022
Q1 		$842K Buy
97,284
+15,366
+19% +$157K ﹤0.01% 3416
2021
Q4 		$1.17M Buy
81,918
+11,772
+17% +$246K ﹤0.01% 3291
2021
Q3 		$1.54M Buy
70,146
+17,242
+33% +$294K ﹤0.01% 3153
2021
Q2 		$707K Buy
+52,904
New +$605K ﹤0.01% 3604

Other funds holding ORMP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
RFW
Redwood Family Wealth Addison, Texas $114M AUM

Bank of New York Mellon's ORMP Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 79,255 shares worth $381K. The stake represents ﹤0.01% of the portfolio and ranks #3876 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in ORMP as recently as Q1 2022.

Bank of New York Mellon first reported a position in ORMP in Q2 2021 and has held it in 5 quarters since. The position peaked at $1.54M in Q3 2021. 26 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Bank of New York Mellon held 79,255 shares of Oramed Pharmaceuticals worth $381K as of Q2 2026.
  • Oramed Pharmaceuticals was a new Bank of New York Mellon position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3876 holding.
  • Bank of New York Mellon first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
  • Bank of New York Mellon's Oramed Pharmaceuticals position peaked at $1.54M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.